NCT05742568 2025-07-03
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
Xijing Hospital of Digestive Diseases
Phase 4 Completed
Clinical Trials
14 trialsNCT06168084 2025-07-03
Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT00357682 2025-05-01
AspECT
University of Oxford
Phase 3 Completed
NCT04678492 2023-01-31
Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT04329000 2020-04-03
On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus.
Kaohsiung Veterans General Hospital.
Phase NA Completed
NCT03609892 2019-08-30
Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT02800330 2018-08-02
REGORA
Erasmus Medical Center
Phase 4 Completed
NCT02730533 2017-07-21
The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD
Xijing Hospital of Digestive Diseases
Phase NA Completed
NCT00474903 2014-07-02
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00473980 2012-04-02
Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients
Göteborg University
Phase 4 Completed
NCT00942175 2012-02-03
A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
Takeda
Phase 1 Completed
NCT00637559 2011-01-25
Barrett's Esophagus - 315 - 3 Way Cross-Over
AstraZeneca
Phase 4 Completed
NCT00637988 2011-01-21
Barrett's Esophagus - 315 - 3 Way Cross Over
AstraZeneca
Phase 4 Completed
NCT00352261 2009-03-26
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
AstraZeneca
Phase 4 Completed